Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies

References

• Zhu C, Popova S, Brown E, Baryste-Lovejoy D, Navab R, Shih W, Li M, Lu M, Jurisica I, Penn L, et al. Integrin alpha11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells. PNAS. 2007; 104(28): 11754–11759.doi:10.1073/pnas.0703040104.
   PubMed Web of Science ®Google Scholar
• Jain T, Sun T, Durand S, Hall A, Houston NR, Nett JH, Sharkey B, Bobrowicz B, Caffry I, Yu Y, et al. Biophysical properties of the clinical-stage antibody landscape. Proc Natl Acad Sci USA. 2017; 114(5): 944–949.doi:10.1073/pnas.1616408114.
   PubMed Web of Science ®Google Scholar
• Haverick M, Mengisen S, Shameem M, Ambrogelly A. Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications. mAbs. 2014;6:.852–858. doi:10.4161/mabs.28693.
   PubMed Web of Science ®Google Scholar
• Kumar S, Singh SK, editors Developability of biotherapeutics: computational approaches. Boca Raton (FL): CRC Press; 2015.
   Google Scholar
• Perchiacca JM, Ladiwala AR, Bhattacharya M, Tessier PM. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions. Protein Eng Des Sel. 2012;25:.591–601. doi:10.1093/protein/gzs042.
   PubMed Web of Science ®Google Scholar
• Courtois F, Schneider CP, Agrawal NJ, Trout BL. Rational design of biobetters with enhanced stability. J Pharm Sci. 2015;104(8):2433–2440. doi:10.1002/jps.24520.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Luo J, O’Neil KT, Kang J, Lacy ER, Canziani G, Baker A, Huang M, Tang QM, Raju TS, et al. Structure-based engineering of a monoclonal antibody for improved solubility. Protein Eng Des Sel. 2010;23:643–651. doi:10.1093/protein/gzq037.
   PubMed Web of Science ®Google Scholar
• Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Design of therapeutic proteins with enhanced stability. Proc Natl Acad Sci USA. 2009;106:.11937–11942. doi:10.1073/pnas.0904191106.
   PubMed Web of Science ®Google Scholar
• Chennamsetty N, Helk B, Voynov V, Kayser V, Trout BL. Aggregation-prone motifs in human immunoglobulin G. J Mol Biol. 2009;391:.404–413. doi:10.1016/j.jmb.2009.06.028.
   PubMed Web of Science ®Google Scholar
• Lauer TM, Agrawal NJ, Chennamsetty N, Egodage K, Helk B, Trout BL. Developability index: a rapid in silico tool for the screening of antibody aggregation propensity. J Pharm Sci. 2012;101:.102–115. doi:10.1002/jps.22758.
   PubMed Web of Science ®Google Scholar
• Sharma VK, Patapoff TW, Kabakoff B, Pai S, Hilario E, Zhang B, Li C, Borisov O, Kelley RF, Chorny I, et al. In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability. Proc Natl Acad Sci USA. 2014;111:18601–18606. doi:10.1073/pnas.1421779112.
   PubMed Web of Science ®Google Scholar
• Salgado JC, Rapaport I, Asenjo JA. Predicting the behavior of proteins in hydrophobic interaction chromatography 1: using the hydrophobic inbalance (HI) to describe their surface amino acid distribution. J Chromatogr A. 2006;1107:.110–119. doi:10.1016/j.chroma.2005.12.032.
   PubMed Web of Science ®Google Scholar
• Salgado JC, Rapaport I, Asenjo JA. Predicting the behavior of proteins in hydrophobic interaction chromatography 2: using a statistical description of their surface amino acid distribution. J Chromatogr A. 2006;1107:.120–129. doi:10.1016/j.chroma.2005.12.033.
   PubMed Web of Science ®Google Scholar
• Karkov HS, Krogh BO, Woo J, Parimal S, Ahmadian H, Cramer SM. Investigation of protein selectivity in multimodal chromatography using in silico designed Fab fragment variants. Biotechnol Bioeng. 2015;112:.2305–2315. doi:10.1002/bit.25642.
   PubMed Web of Science ®Google Scholar
• Tomar DS, Li L, Broulidakis MP, Luksha NG, Burns CT, Singh SK, Kumar S. In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions. mAbs. 2017;9(3):476–489. doi:10.1080/19420862.2017.1285479.
   PubMed Web of Science ®Google Scholar
• Robinson JR, Karkov HS, Woo JA, Krogh BO, Cramer SM. QSAR models for prediction of chromatographic behavior of homologous Fab variants. Biotechnol Bioeng. 2017;114:.1231–1240. doi:10.1002/bit.26236.
   PubMed Web of Science ®Google Scholar
• Insaidoo F, Banerjee S, Roush D, Cramer SM. Computational modeling in bioprocess development. In: Staby A, Rathmore AS, Ahuja S, editors. Preparative chromatography for separation of proteins. Hoboken (USA): Wiley; 2017. doi:10.1002/9781119031116.ch6.
   Google Scholar
• Berliner N, Teyra J, Colak R, Garcia Lopez S, Kim PM. Combining structural modeling with ensemble machine learning to accurately predict protein fold stability and binding affinity effects upon mutation. PLoS ONE. 2014;9(9):e107353. doi:10.1371/journal.pone.0107353.
   PubMed Web of Science ®Google Scholar
• Trainor K, Gingras Z, Shillingford C, Malakian H, Gosselin M, Lipovsek D, Meiering EM. Ensemble modeling and intracellular aggregation of an engineered immunoglobulin-like domain. J Mol Biol. 2016;428:.1365–1374. doi:10.1016/j.jmb.2016.02.016.
   PubMed Web of Science ®Google Scholar
• Persson H, Ye W, Wernimont A, Adams JJ, Koide A, Koide S, Lam R, Sidhu SS. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies. J Mol Biol. 2013;425(4):803–811. doi:10.1016/j.jmb.2012.11.037.
   PubMed Web of Science ®Google Scholar
• Dudgeon K, Rouet R, Kokmeijer I, Schofield P, Stolp J, Langley D, Stock D, Christ D. General strategy for the generation of human antibody variable domains with increased aggregation resistance. Proc Natl Acad Sci USA. 2012;109:.10879–10884. doi:10.1073/pnas.1202866109.
   PubMed Web of Science ®Google Scholar
• Labute P. LowModeMD—implicit low-mode velocity filtering applied to conformational search of macrocycles and protein loops. J Chem Inf Model. 2010;50:.792–800. doi:10.1021/ci900508k.
   PubMed Web of Science ®Google Scholar
• Black SD, Mould DR. Development of hydrophobicity parameters to analyze proteins which bear post- or cotranslational modifications. Anal Biochem. 1991;193:.72–82. doi:10.1016/0003-2697(91)90045-U.
   PubMed Web of Science ®Google Scholar
• Sydow JF, Lipsmeier F, Larraillet V, Hilger M, Mautz B, Molhoj M, Kuentzer J, Klostermann S, Schoch J, Voelger HR, et al. Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions. PloS ONE. 2014; 9(6): e100736.doi:10.1371/journal.pone.0100736.
   PubMed Web of Science ®Google Scholar
• Yang R, Jain T, Lynaugh H, Nobrega RP, Lu X, Boland T, Burnina I, Sun T, Caffry I, Brown M, et al. Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies. mAbs. 2017; 9(4): 646–653.doi:10.1080/19420862.2017.1290753.
   PubMed Web of Science ®Google Scholar
• Almagro JC, Beavers MP, Hernandez-Guzman F, Maier J, Shaulsky J, Butenhof K, Labute P, Thorsteinson N, Kelly K, Teplyakov A, et al. Antibody modeling assessment. Proteins. 2011;79:3050–3066. doi:10.1002/prot.23130.
   PubMed Web of Science ®Google Scholar
• Almagro JC, Teplyakov A, Luo J, Sweet RW, Kodangattil S, Hernandez-Guzman F, Gilliland GL. Second antibody modeling assessment (AMA-II). Proteins. 2014;82:.1553–1562. doi:10.1002/prot.24567.
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE). Montreal (QC, Canada): Chemical Computing Group ULC.; 2016 August.
   Google Scholar
• Maier JKX, Labute P. Assessment of fully automated antibody homology modeling protocols in molecular operating environment. Proteins. 2014;82:.1599–1610. doi:10.1002/prot.24576.
   PubMed Web of Science ®Google Scholar
• Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, Leahy DJ. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature. 2003;421:.756–760. doi:10.1038/nature01392.
   PubMed Web of Science ®Google Scholar
• Leahy DJ, Aukhil I, Erickson HP. 2.0 Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell. 1996;84(1):155–164. doi:10.1016/S0092-8674(00)81002-8.
   PubMed Web of Science ®Google Scholar
• Wildman SA, Crippen GM. Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci. 1999;39(5):868–873. doi:10.1021/ci990307l.
   Google Scholar
• Long WF, Labute P. Calibrative approaches to protein solubility modeling of a mutant series using physicochemical descriptors. J Comput Aided Mol Des. 2010;24:.907–916. doi:10.1007/s10822-010-9383-z.
   PubMed Web of Science ®Google Scholar
• Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L, Barczyk M, et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. PNAS. 2011;108(17):7160–7165. doi:10.1073/pnas.1014506108.
   PubMed Web of Science ®Google Scholar